closo-dodecaborarte (2-) anion as a potential prosthetic group for attachment of astatine to proteins. Aspects of the labelling chemistry with Chloramine-T

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 43, Issue 3, 2000, Pages 251-260

  Orlova, Anna ^a   Lebeda, Ondrej ^b   Tolmachev, Vladimir ^a   Sjöberg, Stefan ^a   Carlsson, Jörgen ^a   Lundqvist, Hans ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b NUCLEAR PHYSICS INSTITUTE   (Czech Republic)

Author keywords

211At; Astatination; Chloramine T; closo dodecaborate (2 ) anion

Indexed keywords

ASTATINE; IONS; PETROLEUM TAR; PROSTHETICS; RADIATION CHEMISTRY; RADIOLYSIS;

211AT; ASTATINATION; CHLORAMINE-T; CLOSO-DODECABORATE (2-) ANION; DIRECT LABELLING; INFLUENCE OF PH; LABELINGS; PH RANGE; PROSTHETIC GROUPS; RADIONUCLIDE THERAPY;

PROTEINS;

ANION; ASTATINE 211; BORIC ACID; CLOSO DODECABORATE; OXIDIZING AGENT; PROTEIN; TOSYLCHLORAMIDE SODIUM; UNCLASSIFIED DRUG; WATER;

ARTICLE; CONTROLLED STUDY; PH; PROTEIN BINDING; RADIOLYSIS; REACTION TIME;

EID: 0034653215     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1344(20000315)43:3<251::AID-JLCR311>3.0.CO;2-Z     Document Type: Article

References (27)

1. Brown I. Appl. Radiat. Isot., 37: 789-798 (1986)
2. Weinreich, R. In: Advances in Hadrontherapy, U.Amaldi, B. Larsson and Y. Lemoigne (Eds.). Elsevier Science, Amsterdam. 1997, pp. 359-382.
3. Vaidyanathan G. and Zalutsky M. R. Phys. Med. Biol. 41:1915-1931 (1996)
4. Visser G.W.M. et al. Int. J. Appl. Radiat. Isot, 32: 905-912 (1981)
5. Zalutsky M. R. and Narula A. S. Appl. Radiat. Isot. 39: 227-232 (1988)
6. Essand M. et al. Cancer Immunol. Immunother. 43: 39-43 (1996)
7. Wilbur D.S. Bioconjugate Chemistry, 3:433-469 (1992)
8. Hadley S.W. et al. Bioconjugate Chem. 2: 171-179 (1991)
9. Wilbur D.S. et al. Nucl. Med. Biol. 20: 917-927 (1993)
10. Schwarz U.P. et al. Nucl. Med. Biol. 25: 89-93. (1998)
11. Knoth W.H. et al. Inorg.Chem. 3: 159-167 (1964)
12. Olsen F.P. and Hawthorn M.F. Inorg. Chem. 4: 1839-1840 (1965)
13. Dunks G.B. and Hawthorn M.F. Inorg. Chem. 9: 893-898 (1970)
14. Mizusawa E.A. et al. Inorg.Chem. 24: 1911-1916 (1985)
15. Hawthorn M.F. Pure&Appl. Chem. 63: 327-334 (1991)
16. Wilbur D. S. et al. J. Label. Compd. Radiopharm. 34/35: 199-201 (1993)
17. Wilbur D.S. et al. Quarternary J. Nucl. Med. 39: 51-52 (1995)
18. Wilbur D.S. et al. In: Proceedings of XIIth International Symposium on Radiopharmaceutical Chemistry. Uppsala, Sweden. June 15-19, 1997 , pp. 76-78.
19. Sjöström A. et al. In: Koziorowski J. "Radiohalogenation of biomolecules. An experimental study on radiohalogen preparation, precursor synthesis, radiolabeling and biodistribution." Acta universitatis Upsaliensis, Uppsala, 1998.
20. Gedda L. et al. Bioconjug Chem. 7: 584-591 (1996)
21. Bruskin A.B. et al. In: Advances in Neutron Capture Therapy, B. Larsson, J.Crawford, R. Weinreich (Eds.). Elsevier, 1997, 2: 46-50
22. Sivaev I.B. et al. Inorg. Chem. (submitted)
23. Sivaev I.B. et al. Tetrahedton Letters, 40: 3451-3455 (1999)
24. Orlova A. and Sjöberg S. In: Proceedings of European Conference on Boron Chemistry, Platja d'Aro, Spain, September 20-24, 1997, p. 114.
25. th Edition, Astatine. H.K.Kugler and C.Keller (Eds.), Springer, Berlin, 1985, pp. 183-209.
26. Visser, G.W.M. Radiochim. Acta, 47: 97-103 (1989)
27. Adams, R.M. et al. Inorg. Chem. 3: 461 (1964)